Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
516.00    2.00 (0.39%)
Bid:
515.00
Ask:
518.00
Spread: 3.00 (0.583%)
Market Cap: £296.92m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

28 Jul 2022 07:00

RNS Number : 9812T
Mortgage Advice Bureau (Hldgs) PLC
28 July 2022
Β 

28 July 2022

Mortgage Advice Bureau (Holdings) plcΒ 

("MAB" or the "Group")

Trading UpdateΒ 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1) today issues a trading update for the six months ended 30 June 2022, ahead of publishing its interim results on 27 September 2022.

Group revenue for the six months ended 30 June 2022 increased to circa Β£95m (H1 2021: Β£92m), up 3% on a comparative period in which mortgage completions had been considerably boosted by the stamp duty holiday changes at the end of March and June 2021.

The average number of mainstream1 advisers during the period increased by 19% to 1,890 (H1 2021: 1,584) with total adviser numbers as at 30 June 2022 up 8% to 2,0342 (31 December 2021: 1,885).

During the first half, the time taken to complete a property purchase increased by approximately one month compared to H1 2021. A number of factors have been delaying transactions, including conveyancing and local authority capacity constraints, down-valuations and expiring mortgage offers that need to be reconsidered and reissued by lenders due to the frequency of UK base rate increases in the period.

Despite the rising cost of living for UK households and further national and geopolitical uncertainty, the level of consumer demand for housing remains strong.

The resilience of demand from people moving home is supported by UK full employment, high levels of household savings and, for those who are subsequent movers, rising housing equity levels over recent years. Lenders also have strong liquidity levels, meaning mortgage availability is now close to pre-pandemic highs, thereby helping market activity to remain healthy.

Although interest rates have risen and will most likely continue to rise over the next 12 months, current interest rates remain near historical lows. As anticipated, increases in interest rates have stimulated more refinancing activity, with mortgage borrowers now more motivated than ever to secure the best possible rate to help their household budgeting.Β 

1 Excludes directly authorised advisers, later life advisers, and advisers from associates in the process of being onboarded under MAB's AR arrangements.

2 Includes a total of 67 advisers at 30 June 2022 who are either directly authorised or later life advisers. The directly authorised advisers are employees of a firm previously authorised under an Appointed Representative agreement with MAB until 7 December 2020. MAB will continue to provide services to this firm, which is now directly authorised by the FCA. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB. Also includes 14 advisers from associates, who are in the process of being onboarded under MAB's AR arrangements. These advisers will shortly become mainstream advisers. Until these 14 advisers become onboarded fully as mainstream advisers, MAB currently only recognises its share of profit after tax from these associates.

Β 

Current trading

The Group has started H2 2022 with a larger than usual pipeline of written business, due to the extended timeframe for completion of housing purchase transactions, and refinancing activity continues to be strong. Whilst we expect consumer demand to cool a little over the coming months, transaction levels are expected to remain healthy.

We were delighted to complete the acquisition of The Fluent Money Group earlier this month, which will allow the enlarged Group to benefit from national lead generation across our entire business sooner than initially anticipated. This reinforces our confidence in the outlook for 2023 and beyond.

Following the period end, the Group increased its stake from 49% to 75% in Vita Financial Limited, a leading protection and general insurance advice firm. This is a strategically important step for the Group as we look to achieve an even stronger market presence in this area.

The Group's adjusted profit before tax for the year ending 31 December 2022 is expected to be in line with market expectations.

Peter Brodnicki, CEO of MAB, commented:

"Despite the obvious frustrations with the pace of completion of housing purchase transactions, our growth plans have been further boosted this year by the acquisition of Fluent Money.

"The expected performance of this strong business, and the leverage it will provide to drive new and significant lead flow into MAB, added to continued strong adviser growth and ongoing enhancements in our technology platform, further supports our plan for accelerated growth into 2023 and beyond regardless of market conditions."

Β 

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Giles Rolls

The information contained within this announcement is deemed by the Company to constitute inside information as stipulatedΒ under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFIRDIIDFIF
Date   Source Headline
11th Dec 20257:00 amRNSDirectorate changes
4th Dec 20259:25 amRNSStandard form for notification of major holdings
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.